Skip to main content

Anti-Rheumatic Rx

      RT @Janetbirdope: #volcosporin good ~lupus nephritis added to #MMF but underbelly - side effects like but ?less than #cy

      Janet Pope Janetbirdope

      3 years 10 months ago
      #volcosporin good ~lupus nephritis added to #MMF but underbelly - side effects like but ?less than #cyclosporin. #FDA update - ⬆️hypertension and nephrotoxicity, infection #ACR21 @RheumNow https://t.co/w5nLLSTlrB
      RT @KDAO2011: "Baseline and routine EKGS are NOT required for SLE patients just because they are on HCQ!" - Dr. HM Belmo

      TheDaoIndex KDAO2011

      3 years 10 months ago
      "Baseline and routine EKGS are NOT required for SLE patients just because they are on HCQ!" - Dr. HM Belmont. "The drug has been demonized due to its use in COVID patients. We don't need to hold HCQ for EMR alerts (e.g, with cipro, SSRIs, etc)." Abstr#1743 #ACR21 @rheumnow https://t.co/5Bxavo6dRg
      RT @doctorRBC: Post-hoc analysis of Deucravacitinib (TYK2i) for tx of PsA showed similar efficacy in pts with and withou

      Robert B Chao, MD doctorRBC

      3 years 10 months ago
      Post-hoc analysis of Deucravacitinib (TYK2i) for tx of PsA showed similar efficacy in pts with and without background csDMARD use. ⭐️>60% w/ background csDMARD use, majority of which was MTX ⭐️no difference in AE #ACR21 Abs#1352 @RheumNow https://t.co/nIJT7rNkJP https://t.co/bq0x1Ywguo
      RT @DrMiniDey: What predicts response to MTX in RA?
      👉🏼DAS28-ESR
      👉🏼RA duration
      👉🏼Pt global assessment
      ð

      Mrinalini Dey DrMiniDey

      3 years 10 months ago
      What predicts response to MTX in RA? 👉🏼DAS28-ESR 👉🏼RA duration 👉🏼Pt global assessment 👉🏼Swollen joint count Abs#1227 #ACR21 @RheumNow https://t.co/s942zvFiZ1
      Methotrexate may be a rheumatologist’s best friend, but a key part of counselling any patient about its use has always been the risk of hepatotoxicity. Despite methotrexate’s near-ubiquitous use in rheumatology, and the consequent frequency of patient counselling about it, relatively little is known about what precautions are absolutely required, a situation which might otherwise provoke anxiety for patients.
      RT @Yuz6Yusof: #ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC:
      ⬇️Titres of Ab

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 10 months ago
      #ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC: ⬇️Titres of Abs in SLE vs controls 💠Factors of poor response: On any DMARDs exc HCQ only (OR 15) and normal dsDNA 📢Important to pause DMARDs in stable SLE @RheumNow https://t.co/USovFkiCRb https://t.co/bn5CC0xRS9
      Fautrel describes a series of 13 #AOSD (Stills) pts with Pulmonary arterial HTN (cath confirmed) - seen exclusively with

      Dr. John Cush RheumNow

      3 years 10 months ago
      Fautrel describes a series of 13 #AOSD (Stills) pts with Pulmonary arterial HTN (cath confirmed) - seen exclusively with women, 85% and all were on DMARDs - 31% MTX, 69% IL-1i, all on steroids- 5 deaths, 3 yr Survival 74% (same as PAH) #ACR21 Abstract 1100 https://t.co/qR21MdYG3A https://t.co/WN38ifgtT6
      RT @ericdeinmd: #ACR21 Abs#1224. ⬇️ CD39 expression on B cell predicts occurrence of anti-drug Ab in RA on RTX
      ⭐ï¸

      Eric Dein ericdeinmd

      3 years 10 months ago
      #ACR21 Abs#1224. ⬇️ CD39 expression on B cell predicts occurrence of anti-drug Ab in RA on RTX ⭐️13/23 pts on RTX became ADAb+. No diff in concomitant MTX usage ⭐️Baseline CD73 similar, but lower CD39 predictive of ADAb https://t.co/QzbAmXtTmZ @Rheumnow https://t.co/CLtEev69YD
      RT @drdavidliew: Atypical patterns of HCQ retinopathy:
      - outside the central macula
      - missed by standard central macula

      David Liew drdavidliew

      3 years 10 months ago
      Atypical patterns of HCQ retinopathy: - outside the central macula - missed by standard central macula screening - 41x more likely in Asians! Lesson: screening with extramacular SD-OCT for Asian HCQ pts is so, so important. 41x over. @MGHrheumatology #ACR21 ABST0989 @RheumNow https://t.co/0w7ALHJDSW
      The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 2 (#ACRbest).
      RT @AkhilSoodMD: Another exciting day at #ACR21 and covering for @RheumNow
      Also presented my poster (Abstr 0587) DMARD

      Akhil Sood MD AkhilSoodMD

      3 years 10 months ago
      Another exciting day at #ACR21 and covering for @RheumNow Also presented my poster (Abstr 0587) DMARD Use in Medicare Patients with #RheumatoidArthritis and Risk of Long-Term Opioid Use - DMARD users showed lower odds of long term opioid use compared to non-DMARD users https://t.co/2XZgYY8ORg
      RT @_Castillo_Pedro: Stopping/reducing hydroxychloroquine (HCQ) in SLE associated with increased flares, especially for

      Pedro Castillo _Castillo_Pedro

      3 years 10 months ago
      Stopping/reducing hydroxychloroquine (HCQ) in SLE associated with increased flares, especially for those in low disease activity or in remission. Super helpful data to share with pts wanting to reduce/dc HCQ. #ACR21 Abst#0959 Plenary Session II @RheumNow https://t.co/i7jPDN2sgZ
      The first full day of Abstracts and Presentations from ACR Convergence, was full of highly engaging sessions, quality posters and unique presentations. To hear more about the best of the best, I would encourage you to look at our Day 1 Recap Video and Day 1 ACR Best Abstracts. Here are a few of my favorites from the first day.
      ×